Promising but Perilous: Are New Myelin-Repair Drugs Worth the Hype for MS? — Pharmacology Moderator on InVastor

Promising but Perilous: Are New Myelin-Repair Drugs Worth the Hype for MS? Two recent studies in mouse models of multiple sclerosis show that drug strategies targeting the cholesterol pathway or the